Table 1.
Baseline characteristics of the patients included in the study at day 0
| Baseline characteristics | |
|---|---|
| Patients (n) | 98 |
| Gender | |
| Sex ratio n (%) | 0.96 |
| Male | 48 (49.0%) |
| Female | 50 (51.0%) |
| Age | |
| Median age (IQR) (years) | 11.5 (6–18.8) |
| <8 years n (%) | 39 (39.8%) |
| 8–15 years n (%) | 23 (23.5%) |
| >15 years n (%) | 36 (36.7%) |
| Body weight (n = 96) | |
| Median body weight (IQR) (kg) | 33 (21–57) |
| <25 kg n (%) | 37 (38.5%) |
| ≥25 kg n (%) | 59 (61.5%) |
| Temperature | |
| Median (IQR) (°C) | 38.2 (37–39.5) |
| Fever (temperature ≥ 38 °C) n (%) | 51 (52.0%) |
| Symptoms n (%) | |
| Headache | 66 (67.3%) |
| Vomiting | 42 (42.9%) |
| Diarrhoea | 8 (8.2%) |
| Diffuse pain | 9 (9.2%) |
| P. falciparum asexual parasite density | |
| Median parasitaemia (IQR) (parasites/µl) | 42,332 (17,893–87,302) |
| Anti-malarial dose (mg/kg) (n = 96) | |
| DHA Median (IQR) | 2.5 (2.0–3.0) |
| PPQ Median (IQR) | 19.8 (16.3–24) |